Copper Peroxides Based Multiple Tumor Microenvironment Regulation for Enhanced Photodynamic/Chemodynamic Synergistic Therapy
Source abstract
Abstract
Abstract Hypoxia, overexpressed glutathione (GSH) and depletable H2O2 in tumor microenvironment (TME) are three major obstacles to the development of reactive oxygen species (ROS)‐mediated antitumor therapy. Herein, a photodynamic/chemodynamic synergistic therapeutic nanoagent, DMOS@CuO2/ICG‐HA (DCI), is synthesized based on copper peroxide (CuO2) and indocyanine green (ICG) co‐loaded disulfide‐bond‐incorporated dendritic mesoporous organosilica (DMOS), with modification of hyaluronic acid (HA). The DCI nanocomposites (NCs) can realize multiple TME regulating ability through releasing H2O2/O2 and depleting GSH under acidic condition. Besides, the released Cu2+ can contribute to T1‐weighted magnetic resonance imaging (MRI) in vitro and in vivo. After accumulating at the tumor sites, the DCI NCs can overcome the hypoxia and produce high level of ROS to induce cell apoptosis upon laser irradiation. Hence, the as‐prepared DCI nanoagent can realize MRI‐guided synergistic photodynamic/chemodynamic therapy with enhanced antitumor efficacy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Cancer, Stress, Anesthesia, and Immune Response
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 P. R. China
Funding
National Key Research and Development Program of China · National Natural Science Foundation of China
References (32)
Show source-provided references
1. 10.1002/adma.20190715210.1002/adma.201907152 ↗
2. 10.1002/advs.20200185310.1002/advs.202001853 ↗
3. 10.1038/s41467-021-24961-510.1038/s41467-021-24961-5 ↗
4. 10.1002/adhm.20200124010.1002/adhm.202001240 ↗
5. 10.1002/adma.20210397810.1002/adma.202103978 ↗
6. 10.1021/jacs.8b0107210.1021/jacs.8b01072 ↗
7. 10.1016/j.nantod.2020.10094610.1016/j.nantod.2020.100946 ↗
8. 10.1021/jacs.0c0560410.1021/jacs.0c05604 ↗
9. 10.1002/adma.20210122310.1002/adma.202101223 ↗
10. 10.1038/s41467-018-08234-210.1038/s41467-018-08234-2 ↗
11. 10.1016/j.actbio.2021.11.00710.1016/j.actbio.2021.11.007 ↗
12. 10.1039/D0SC02937H10.1039/D0SC02937H ↗
13. 10.1002/adfm.20190619510.1002/adfm.201906195 ↗
14. 10.1021/acsami.0c1907410.1021/acsami.0c19074 ↗
15. 10.1002/advs.20190213710.1002/advs.201902137 ↗
16. 10.1021/acs.nanolett.0c0004710.1021/acs.nanolett.0c00047 ↗
17. 10.1002/ange.20210925810.1002/ange.202109258 ↗
18. 10.1021/acsami.0c1068510.1021/acsami.0c10685 ↗
19. 10.1002/adfm.20190859810.1002/adfm.201908598 ↗
20. 10.1021/acs.chemmater.9b0089310.1021/acs.chemmater.9b00893 ↗
21. 10.1002/smll.20220353110.1002/smll.202203531 ↗
22. 10.1002/adma.20190527110.1002/adma.201905271 ↗
23. 10.1002/advs.20180173310.1002/advs.201801733 ↗
24. 10.1007/s12274-020-2844-310.1007/s12274-020-2844-3 ↗
25. 10.1016/j.chempr.2019.06.00310.1016/j.chempr.2019.06.003 ↗
26. 10.1016/j.jhazmat.2019.04.05810.1016/j.jhazmat.2019.04.058 ↗
27. 10.7150/thno.3983110.7150/thno.39831 ↗
28. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
29. 10.1002/ange.20190398110.1002/ange.201903981 ↗
30. 10.1021/acsnano.0c1075610.1021/acsnano.0c10756 ↗
31. 10.1002/adhm.20200120510.1002/adhm.202001205 ↗
32. 10.1021/acsnano.1c0789310.1021/acsnano.1c07893 ↗